Reviv3 Procare Q2 FY2024 net sales up 25.1% to record $8.4M, net income up 40.1% to $1.02M

Axil Brands, Inc.

2024-Q2 EPS reported $0.00 revenue$14,527,946

Net sales record $8.4M (Q2 Nov 30, 2023) vs $6.7M a year ago, up 25.1%.
Net income increased 40.1% to $1.02M from $726,900; sixth consecutive profitable quarter.
Gross margin 74.3% vs 74.9%; operating expenses 59.3% of sales vs 60.2%.
Cash $5.96M (Nov 30, 2023) vs $4.83M (May 31, 2023).
EPS basic $0.01, diluted $0.00; basic shares 117.1M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Axil Brands, Inc. reported the second quarter ended November 30, 2023 results: revenue $8.4 million, net income $1,018,075.

Period: the second quarter ended November 30, 2023
Revenue: $8.4 million
Net income: $1,018,075
Result: reported results

Exact text from the filing

2 rviv-20240104_8kex99z1.htm EXHIBIT 99.1 REVIV3 Procare Company Reports Record Second Quarter Fiscal Year 2024 Financial Results Net Sales (revenue) increased 25.1% to a record $8.4 million for the second quarter ended November 30, 2023, as compared to the prior year period. Gross Profit (as a percentage of Net Sales) was 74.3% as compared to 74.9% for the prior

View on SEC.gov

Browse all earnings releases →

Axil Brands, Inc. filing history →

Source: SEC EDGAR

accession 0001520138-24-000006

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.